Alexander D. MACKERELL, JR.
28Patents
5h-index
38Co-inventors
69Inventor score
Filing activity: Jul 31, 2001 → Oct 18, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8338464B2 | Small molecule inhibitors of BCL6 | Chemistry; Metallurgy | 27 | Active |
| US11078171B2 | Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US11357781B2 | Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US7915245B2 | Methods and compositions of trail-death receptor agonists/activators | Human Necessities | 7 | Active |
| US9115122B2 | Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) | Chemistry; Metallurgy | 5 | Active |
| US8785499B2 | Targeting NAD biosynthesis in bacterial pathogens | Human Necessities | 3 | Active |
| US8796323B2 | Defensin-like molecules as novel antimicrobial agents | Human Necessities | 3 | Active |
| US8445537B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 3 | Active |
| US11718595B2 | Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9351963B2 | Defensin-like molecules as novel antimicrobial agents | Human Necessities | 2 | Active |
| US9073896B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 1 | Active |
| US7521463B2 | Immunomodulatory compounds | Human Necessities | 1 | Expired |
| US11911392B2 | Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12404259B2 | Inhibitors of extracellular signal-regulated kinase | Human Necessities | 0 | Active |
| US9757375B2 | Compounds that inhibit human DNA ligases and methods of treating cancer | Physics | 0 | Active |
| US8053477B2 | Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same | Human Necessities | 0 | Expired |
| US10941114B2 | Small molecule lipid II inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10961214B2 | Small molecule lipid II inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11911393B2 | Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US8476273B2 | Small molecule inhibitors of Lck SH2 domain binding | Human Necessities | 0 | Active |
| US12202810B2 | Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9701627B2 | LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders | Chemistry; Metallurgy | 0 | Active |
| US9422302B2 | Mixed μ agonist/ δ antagonist opioid analgesics with reduced tolerance liabilities and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11510908B2 | Protein translation inhibitors and uses thereof | Human Necessities | 0 | Active |
| US11634381B2 | RUNX2 transcription factor inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.